- Y. James Kang, Sichuan University, China and University of Louisville, USA
Society affiliationsRegenerative Medicine Research is the official journal of The Regenerative Medicine Research, Application and Compliance Consortium (RMRACC).
Aims & scope
Regenerative Medicine Research is an open access, online journal that publishes research relating to both the fundamental and practical aspects of regenerative medicine, with a particular emphasis on translational research.
Dr Y. James Kang is China National One Thousand Talents Professor and Director of the Regenerative Medicine Research Center at the Sichuan University West China Hospital. He is also affiliated with the Department of Pharmacology and Toxicology, university of Louisville School of Medicine.
Dr Kang received PhD in Toxicology and Zoology (Cell Biology) from Iowa State University in 1989 and completed postdoctoral training in Biochemistry and Molecular Biology at Cornell University Medical Center in 1990. He was Assistant Professor of Pharmacology and Toxicology, University of North Dakota School of Medicine (1991-1996); Associate Professor of Medicine, Pharmacology and Toxicology and University Scholar, University of Louisville School of Medicine (1996-2001), then promoted to Professor and Distinguished University Scholar in 2001. He has served as the director of the Regenerative Medicine Research Center since 2009.
He had served several US NIH study sections from 1997 to 2006, and other federal agencies including USDA, US-EPA and US-Veterans Administrations from 1996 to 2005. He was elected as Fellow of the Academy of Toxicological Sciences in 2001. As well as being Editor-in-Chief of Regenerative Medicine Research he also heads up the Springer journal, Cardiovascular Toxicology and edits the book series Methods in Pharmacology and Toxicology. Dr Kang currently serves the council for the Society for Experimental Biology and Medicine, and Chairs their publication committee. His research interests include regenerative medicine - focusing on cardiovascular regeneration, dietary manipulation of cardiovascular disease, liver fibrosis and cirrhosis, oxidative stress and antioxidant mechanisms, metallothionein and glutathione, and non-human primate models for human diseases.
From the blog
- 06 December 2013
- The potential uses of EPCs in cardiovascular disease